Global Thalassemia Market and Competitive Landscape Report 2017 - Forecasts to 2021 & 2025 - Research and Markets

DUBLIN--()--The "Global Thalassemia Market and Competitive Landscape - 2017" report has been added to Research and Markets' offering.

The report is classified into twelve sections - Thalassemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Thalassemia pipeline insights covering late stage clinical trials pipeline; Thalassemia prevalence trends by countries; Thalassemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Thalassemia pipeline: Find out the drugs in clinical trials for Thalassemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Thalassemia epidemiology: Find out the prevalence of Thalassemia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Thalassemia products: Identify key products marketed and prescribed for Thalassemia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Thalassemia market size: Find out the market size for Thalassemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Thalassemia drug sales: Find out the sales of Thalassemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Thalassemia drugs sales forecast: Sales forecast for Thalassemia drugs to 2021 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Thalassemia market share analysis: Find out the market shares of Thalassemia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/srs88p/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs